Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
CPSE:NOVO B
Novo Nordisk A/S
|
912.90 | -2,1% | 18,21% | 4.066.820,23 | 1,02% | 18,5% |
|
NasdaqGS:BIIB
Biogen
|
230.04 | -15,03% | 0,05% | 33.493,11 | 0% | -10,89% |
|
NYSE:DD
DuPont de Nemours
|
77.57 | -0,23% | 18,03% | 32.432,36 | 1,94% | -22,35% |
|
BSE:500124
Dr. Reddy's Laboratories
|
5840.45 | 16,88% | 19% | 977.652,02 | 0,68% | 24,23% |
|
NasdaqCM:NKTR
Nektar Therapeutics
|
1.80 | 0% | 0% | 301,14 | 0% | 0% |
|
OTCPK:ENZN
Enzon Pharmaceuticals
|
0.09 | 0% | 0% | 8,48 | 0% | 0% |
